URO TODAY: Active surveillance protocols can be valuable when prostate cancer is managed well and treatment is recommended appropriately, according to two recent studies. READ MORE>
Posts Tagged ‘active surveillance protocols’
Active surveillance appropriate for low-risk prostate cancer, studies show
Posted in PROSTATE CANCER, Watchful waiting, tagged active surveillance, active surveillance protocols, cancer research, catheter, low-risk prostate cancer, prostate, PROSTATE CANCER, URO TODAY on June 3, 2010| Leave a Comment »
Urologists take more balanced view of prostate cancer testing in submission to NZ parliamentary inquiry
Posted in PROSTATE CANCER, PROSTATE RESEARCH, PSA tests, Screening debate, tagged active surveillance protocols, better markers, Biopsy, blood tests, catheter, consultation with patients, diagnostic methods, digital diagnosis, digital examination, health bureaucrats, medical checkups, Ministry of Health, NZ urologists, Over-treatment, Parliamentary Health Select Committee inquiry, prostablog, prostate blog, PROSTATE CANCER, prostate cancer screening, prostate treatment debate, prostate-specific antigen, PSA test, Screening debate, strong opposition, surgery, Urological Society of Australia and NZ on October 22, 2009| Leave a Comment »
PROSTABLOG NZ: Not surprisingly, NZ urologists – the doctors who operate on prostate cancer patients – are more circumspect than the country’s health bureaucrats when it comes to assessing the value of PSA and digital tests.
That became obvious at this week’s hearings by the Parliamentary Health Select Committee inquiry into prostate cancer detection and treatment.
A submission by the Urological Society of Australia and NZ takes a more balanced view of testing than those allied to the Ministry of Health, who gave their evidence last month and expressed strong opposition.
The society says, in essence, that PSA tests and digital exams aren’t foolproof, but if used judiciously – that is, in conjunction with other diagnostic methods and with proper consultation with patients – they undoubtedly save lives.
Along with many overseas groups, they urge more research to find better markers, and particularly recommend the development of protocols to enhance the option of active surveillance.